Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Beginning Cash Balance: 2016-2025

Historic Beginning Cash Balance for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $117.3 million.

  • Collegium Pharmaceutical's Beginning Cash Balance fell 20.66% to $117.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.1 million, marking a year-over-year decrease of 81.11%. This contributed to the annual value of $213.9 million for FY2024, which is 22.12% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Beginning Cash Balance is $117.3 million, which was up 21.99% from $96.2 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Beginning Cash Balance ranged from a high of $283.7 million in Q3 2023 and a low of $39.0 million during Q4 2024.
  • In the last 3 years, Collegium Pharmaceutical's Beginning Cash Balance had a median value of $173.7 million in 2023 and averaged $175.5 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Beginning Cash Balance surged by 153.97% in 2023 and then tumbled by 84.93% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Beginning Cash Balance (Quarterly) stood at $193.2 million in 2021, then slumped by 30.59% to $134.1 million in 2022, then soared by 92.75% to $258.5 million in 2023, then crashed by 84.93% to $39.0 million in 2024, then declined by 20.66% to $117.3 million in 2025.
  • Its last three reported values are $117.3 million in Q3 2025, $96.2 million for Q2 2025, and $75.7 million during Q1 2025.